Cross-presentation in viral immunity and self-tolerance

Nature Reviews. Immunology
W R Heath, F R Carbone

Abstract

T lymphocytes recognize peptide antigens presented by class I and class II molecules encoded by the major histocompatibility complex (MHC). Classical antigen-presentation studies showed that MHC class I molecules present peptides derived from proteins synthesized within the cell, whereas MHC class II molecules present exogenous proteins captured from the environment. Emerging evidence indicates, however, that dendritic cells have a specialized capacity to process exogenous antigens into the MHC class I pathway. This function, known as cross-presentation, provides the immune system with an important mechanism for generating immunity to viruses and tolerance to self.

References

Feb 1, 1990·The Journal of Experimental Medicine·F R Carbone, M J Bevan
Jan 1, 1989·Advances in Cancer Research·S PääboP A Peterson
Jun 1, 1995·European Journal of Immunology·M F BachmannR M Zinkernagel
Jan 1, 1994·Immunogenetics·C De SmetT Boon
Feb 1, 1994·European Journal of Immunology·G SchönrichB Arnold
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M Kovacsovics-BankowskiK L Rock
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·K AhnK Früh
Oct 1, 1996·The Journal of Experimental Medicine·T De SmedtM Moser
Dec 1, 1996·European Journal of Immunology·I Förster, I Lieberam
Sep 1, 1996·The Journal of Experimental Medicine·C KurtsH Kosaka
Jul 7, 1997·The Journal of Experimental Medicine·S R BennettW R Heath
Sep 18, 1997·The Journal of Experimental Medicine·I Fugier-VivierC Rabourdin-Combe
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·J LevitskayaM G Masucci
Dec 16, 1998·Immunological Reviews·J F MillerW R Heath
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·D J MorganL A Sherman

❮ Previous
Next ❯

Citations

Dec 14, 2004·European Journal of Immunology·Winfried BarchetMarco Colonna
Jul 21, 2005·Cancer Immunology, Immunotherapy : CII·Min Yu, Olivera J Finn
Jul 20, 2007·Cancer Immunology, Immunotherapy : CII·Hidenobu OchiaiJohn H Sampson
Dec 21, 2004·Springer Seminars in Immunopathology·Kenneth L RockYan Shi
Dec 21, 2004·Springer Seminars in Immunopathology·Sandip K Datta, Eyal Raz
Dec 14, 2004·Springer Seminars in Immunopathology·Pierre Guermonprez, Sebastian Amigorena
Jun 21, 2005·Springer Seminars in Immunopathology·Adrian F Ochsenbein
Jun 2, 2007·Medical Microbiology and Immunology·Jindrich CinatlHans W Doerr
Oct 5, 2007·Molecular Biotechnology·David W O'Neill, Nina Bhardwaj
Mar 24, 2004·Molecular Immunology·Jean-Marie FourneauJean-François Bach
Nov 20, 2003·Trends in Cell Biology·Sylvain BrunetMichel Desjardins
Jun 24, 2003·Comparative Immunology, Microbiology and Infectious Diseases·Claude Leclerc
Apr 23, 2003·Immunology Letters·Dominik Wodarz, Vincent A A Jansen
Aug 6, 2003·Current Opinion in Immunology·Francis R Carbone, William R Heath
Dec 24, 2002·Current Opinion in Immunology·Christopher C Norbury, Luis J Sigal
Mar 5, 2003·Trends in Immunology·Viktor Müller, Sebastian Bonhoeffer
Dec 21, 2006·Nature Immunology·Rolf Zinkernagel
Mar 22, 2006·Nature Immunology·Michael J Bevan
May 3, 2005·Nature Reviews. Cancer·Richard A Lake, Bruce W S Robinson
Mar 27, 2002·Nature Reviews. Immunology·Ken Shortman, Yong-Jun Liu
Mar 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Herman N EisenRichard J Cohen
Oct 23, 2002·The Journal of Experimental Medicine·Gabrielle T BelzWilliam R Heath
Oct 23, 2002·The Journal of Experimental Medicine·Kang LiuRalph M Steinman
Oct 23, 2002·The Journal of Experimental Medicine·Evelyne MougneauNicolas Glaichenhaus
Aug 27, 2003·The Journal of Experimental Medicine·Sylvain FissonBenoît L Salomon
Jul 31, 2004·Immunology and Cell Biology·Rolf M Zinkernagel
Jan 19, 2006·Clinical Microbiology Reviews·Robert S FujinamiJ Lindsay Whitton
Sep 21, 2007·Journal of Virology·Avi-Hai HovavNorman L Letvin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.